本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Eledon Pharmaceuticals, Inc.

2.77
-0.0100-0.36%
成交量:52.08萬
成交額:144.87萬
市值:2.25億
市盈率:-2.81
高:2.88
開:2.88
低:2.75
收:2.78
52周最高:4.60
52周最低:1.35
股本:8,126.12萬
流通股本:7,456.71萬
量比:0.61
換手率:0.70%
股息:- -
股息率:- -
每股收益(TTM):-0.9867
每股收益(LYR):-0.5566
淨資產收益率:-110.71%
總資產收益率:-39.02%
市淨率:3.12
市盈率(LYR):-4.98

資料載入中...

2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/23

重要事件披露

8-K - Current report
2022/05/31

重要事件披露

8-K - Current report
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/26

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/13

重要事件披露

8-K - Current report
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/08/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/09

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/07/02

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/05/18

SEC問詢函

CORRESP [Cover] - Correspondence